Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1000
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1000
Neural Regulation01:37

Neural Regulation

43.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion.

eLife·2026
Same author

Sorcin couples Annexin A11 recruitment and ESCRT-III assembly during plasma membrane repair.

bioRxiv : the preprint server for biology·2026
Same author

p62 sorts Lupus La and selected microRNAs into breast cancer-derived exosomes.

The Journal of cell biology·2025
Same author

Endosome transcriptomics reveal trafficking of Cajal bodies into multivesicular bodies.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Calpains orchestrate secretion of annexin-containing microvesicles during membrane repair.

The Journal of cell biology·2025
Same author

p62 sorts Lupus La and selected microRNAs into breast cancer-derived exosomes.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Jan 19, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.4K

Coordinating a new approach to basic research into Parkinson's disease.

Randy Schekman1, Ekemini Au Riley2

  • 1Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, United States.

Elife
|September 26, 2019
PubMed
Summary

The Aligning Science Across Parkinson's (ASAP) initiative fosters global research collaboration to understand Parkinson's disease biology. This network aims to uncover disease origins and progression for developing novel therapeutic strategies.

Keywords:
Parkinson's diseasehuman biologymedicineneurodegenerative disordersneurosciencenoneopen scienceorganization of researchphilanthropyteam science

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.0K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.4K

Related Experiment Videos

Last Updated: Jan 19, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.4K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.0K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.4K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Parkinson's disease (PD) is a complex neurodegenerative disorder with incompletely understood etiology.
  • Current therapeutic strategies primarily manage symptoms, highlighting the need for disease-modifying treatments.
  • The existing research landscape for PD is fragmented, necessitating enhanced collaboration.

Purpose of the Study:

  • To establish an international research network focused on elucidating the biological underpinnings of Parkinson's disease.
  • To accelerate the discovery of Parkinson's disease origins and progression mechanisms.
  • To foster collaborative research and promote open-science practices within the Parkinson's disease community.

Main Methods:

  • Establishing a global consortium of researchers from diverse scientific disciplines.
  • Incentivizing interdisciplinary collaboration through dedicated funding and shared resources.
  • Implementing open-science principles to facilitate data sharing and knowledge dissemination.

Main Results:

  • An international network of researchers is actively engaged in Parkinson's disease research.
  • Enhanced collaboration between traditional PD researchers and experts from other fields is being fostered.
  • Commitment to open-science practices is central to the initiative's operational framework.

Conclusions:

  • The Aligning Science Across Parkinson's initiative is creating a collaborative ecosystem to advance Parkinson's disease research.
  • Understanding the fundamental biology of Parkinson's disease is crucial for developing effective therapies.
  • The initiative's focus on collaboration and open science is expected to accelerate therapeutic breakthroughs.